Oncology Central

Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials

0

During recent decades, major advances in the comprehension of biology and in biotechnologies have paved the way for what is commonly named personalized medicine. For cancer therapy, personalized medicine represents a paradigm shift in which patient treatment is based on biology in addition to histology and tumor location.

To view restricted content, please:
Share:

Leave A Comment